FASEB Growth Factor Receptor Tyrosine Kinases Confence

描述(由申请人提供) 此应用程序正在请求部分资金以支持第二个产品 关于“生长因子受体”的一次独特的FASE夏季研究会议 酪氨酸激酶在有丝分裂、形态发生和肿瘤发生中的作用“待定 2001年8月4日至8月9日在科罗拉多州斯诺马斯村举行。基于 第一届FASEB夏季研究会议总体上取得了重大成功 主题在1999年夏季举行，本届会议将继续关注 红斑狼疮细胞分子生物学及病理生理学研究新进展 与生长因子酪氨酸激酶相关的几类重要分子 有丝分裂，组织再生和发育，形态发生， 肿瘤的发生、发展、侵袭和转移。符合 之前与会者的一致观点，受体的erbB和Met家族 我们将再次强调酪氨酸激酶。此外，小说会议将 在细胞外基质信号转导、受体酪氨酸激酶结构域上被持有 和新药开发，受体酪氨酸的治疗靶向 恶性疾病中的激酶，非恶性疾病中的生长因子治疗， 以及RON/STK受体酪氨酸激酶的生物学和病理生物学。 科学计划将包括25个受邀的平台演示 演讲者，其中大多数是该领域的知名领导人。此外， 课程将包括大量精选的摘要驱动型口语 报告，以及根据提交的摘要举行的海报会议。一个 青年调查员小型研讨会，事实证明是一个非常成功的 作为第一次会议的组成部分，它将再次成为 当前会议。为了提供一个最大限度的科学气候 与会者之间的互动，会议出席人数将限于 100至195名调查员(包括特邀演讲者)，从 基于他们的专业知识和最近对 科学文献。将尽一切努力确保适当的组合 成熟的和年轻的调查人员，特别是妇女和少数群体 鼓励参与。像第一次会议，第二次会议 预计将相当成功，并再次成为最先进的 生长因子受体酪氨酸激酶的科学论坛将促进 有机会进行富有成效的新研究互动并满足 FASEB夏季研究会议的高标准。

DESCRIPTION (provided by applicant) This application is requesting partial funding to support the second offering of a unique FASEB Summer Research Conference on "Growth Factor Receptor Tyrosine Kinases in Mitogenesis, Morphogenesis, and Tumorgenesis" to be held at Snowmass Village, Colorado from August 4 to August 9, 2001. Based on the overall major success of the first FASEB Summer Research Conference on this subject held in the Summer 1999, the current Conference will continue to focus on new developments in the cell and molecular biology and pathophysiology of important classes of growth factor tyrosine kinases as they relate to mitogenesis, tissue regeneration and development, morphogenesis, tumorigenesis, progression, and invasion and metastasis. In line with the unanimous view of previous attendees, the erbB and Met families of receptor tyrosine kinases will again be emphasized. In addition, novel sessions will be held on extracellular matrix signaling, receptor tyrosine kinase domains and new small drug development, therapeutic targeting of receptor tyrosine kinases in malignant disease, growth factor therapy in non-malignant diseases, and on the biology and pathobiology of the Ron/Stk receptor tyrosine kinase. The Scientific Program will include platform presentations by 25 Invited Speakers, a majority of whom are renown leaders in the field. Moreover, the program will include a significant number of selected Abstract-driven oral presentations, as well as a Poster Session based on submitted abstracts. A Young Investigator Mini-Symposium, which proved to be a highly successful component of the first conference, will again serve as a highlight of the current conference. In order to provide a climate maximizing scientific interaction among the participants, conference attendance will be limited to between 100 and 195 investigators (including Invited Speakers), selected from applications based on their expertise and recent contributions to the scientific literature. Every effort will be made to insure a proper mix of established and young investigators, with women and minorities particularly encourage to participate. Like the first conference, this second conference is anticipated to be quite successful and to again serve as a state-of-the-art scientific forum on growth factor receptor tyrosine kinases that will foster opportunities for productive new research interactions as well as meet the high standards of a FASEB Summer Research Conference.